| 0 |
INTERNAL HERNIA |
1 |
0.0060 |
| 1 |
INFUSION SITE INJURY |
1 |
0.0057 |
| 2 |
PRODUCT ADVERTISING ISSUE |
1 |
0.0047 |
| 3 |
COLD URTICARIA |
1 |
0.0045 |
| 4 |
GENITAL DISCHARGE |
1 |
0.0042 |
| 5 |
PNEUMOTHORAX TRAUMATIC |
1 |
0.0041 |
| 6 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 7 |
ALLERGY TO ARTHROPOD STING |
1 |
0.0022 |
| 8 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
1 |
0.0018 |
| 9 |
HYPOAESTHESIA EYE |
1 |
0.0017 |
| 10 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 11 |
CATHETER SITE RELATED REACTION |
1 |
0.0013 |
| 12 |
INFECTION PARASITIC |
1 |
0.0013 |
| 13 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 14 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 15 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 16 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 17 |
INFUSION SITE MASS |
1 |
0.0009 |
| 18 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 19 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 20 |
CLUSTER HEADACHE |
1 |
0.0007 |
| 21 |
STRONGYLOIDIASIS |
1 |
0.0006 |
| 22 |
LAZINESS |
1 |
0.0006 |
| 23 |
LIP DISORDER |
1 |
0.0005 |
| 24 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 25 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 26 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 27 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 28 |
INFUSION SITE INFECTION |
1 |
0.0004 |
| 29 |
ORAL SURGERY |
1 |
0.0004 |
| 30 |
PUSTULE |
1 |
0.0004 |
| 31 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 32 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 33 |
EAR CONGESTION |
1 |
0.0004 |
| 34 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 35 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 36 |
THERAPEUTIC AGENT TOXICITY |
1 |
0.0003 |
| 37 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 38 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 39 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 40 |
OBSTRUCTION |
1 |
0.0003 |
| 41 |
IMMOBILE |
1 |
0.0002 |
| 42 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 43 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 44 |
TRISMUS |
1 |
0.0002 |
| 45 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 46 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 47 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 48 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 49 |
BRONCHIECTASIS |
1 |
0.0001 |
| 50 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 51 |
FORMICATION |
1 |
0.0001 |
| 52 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 53 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 54 |
PANIC REACTION |
1 |
0.0001 |
| 55 |
ARTHROPOD BITE |
1 |
0.0001 |
| 56 |
FEELING DRUNK |
1 |
0.0001 |
| 57 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 58 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 59 |
MUSCLE INJURY |
1 |
0.0001 |
| 60 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 61 |
FACIAL PAIN |
1 |
0.0001 |
| 62 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 63 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 64 |
HERNIA |
2 |
0.0001 |
| 65 |
PARKINSONISM |
1 |
0.0001 |
| 66 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 67 |
EMPHYSEMA |
1 |
0.0001 |
| 68 |
EUPHORIC MOOD |
1 |
0.0001 |
| 69 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 70 |
SCRATCH |
1 |
0.0001 |
| 71 |
VIRAL INFECTION |
3 |
0.0001 |
| 72 |
SKIN INFECTION |
1 |
0.0001 |
| 73 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 74 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 75 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 76 |
TOOTH INFECTION |
1 |
0.0001 |
| 77 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 78 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 79 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 80 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 81 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 82 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 83 |
COVID-19 |
11 |
0.0001 |
| 84 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 85 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 86 |
PHOTOPHOBIA |
1 |
0.0001 |
| 87 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 88 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 89 |
EAR PAIN |
1 |
0.0001 |
| 90 |
NASAL CONGESTION |
3 |
0.0001 |
| 91 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 92 |
RIB FRACTURE |
1 |
0.0000 |
| 93 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 94 |
SKIN CANCER |
1 |
0.0000 |
| 95 |
GLOSSODYNIA |
1 |
0.0000 |
| 96 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 97 |
PRESYNCOPE |
1 |
0.0000 |
| 98 |
BRONCHITIS |
3 |
0.0000 |
| 99 |
AGEUSIA |
1 |
0.0000 |
| 100 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 101 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 102 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 103 |
GASTRITIS |
1 |
0.0000 |
| 104 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 105 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 106 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 107 |
DYSSTASIA |
1 |
0.0000 |
| 108 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 109 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 110 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 111 |
VERTIGO |
2 |
0.0000 |
| 112 |
FEELING HOT |
2 |
0.0000 |
| 113 |
FEMUR FRACTURE |
1 |
0.0000 |
| 114 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 115 |
HEAD INJURY |
1 |
0.0000 |
| 116 |
CYSTITIS |
1 |
0.0000 |
| 117 |
NIGHT SWEATS |
1 |
0.0000 |
| 118 |
FUNGAL INFECTION |
1 |
0.0000 |
| 119 |
GAIT INABILITY |
1 |
0.0000 |
| 120 |
EYE PRURITUS |
1 |
0.0000 |
| 121 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 122 |
DELIRIUM |
1 |
0.0000 |
| 123 |
HEART RATE DECREASED |
1 |
0.0000 |
| 124 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 125 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 126 |
RESTLESSNESS |
1 |
0.0000 |
| 127 |
DYSURIA |
1 |
0.0000 |
| 128 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 129 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 130 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 131 |
DISORIENTATION |
1 |
0.0000 |
| 132 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 133 |
BALANCE DISORDER |
2 |
0.0000 |
| 134 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 135 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 136 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 137 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 138 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 139 |
COUGH |
6 |
0.0000 |
| 140 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 141 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 142 |
LUNG DISORDER |
1 |
0.0000 |
| 143 |
DYSPEPSIA |
2 |
0.0000 |
| 144 |
FLUSHING |
2 |
0.0000 |
| 145 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 146 |
SINUSITIS |
2 |
0.0000 |
| 147 |
ECZEMA |
1 |
0.0000 |
| 148 |
PARAESTHESIA |
3 |
0.0000 |
| 149 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 150 |
EYE PAIN |
1 |
0.0000 |
| 151 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 152 |
DYSPHONIA |
1 |
0.0000 |
| 153 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 154 |
ASTHENIA |
6 |
0.0000 |
| 155 |
PNEUMONIA |
5 |
0.0000 |
| 156 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 157 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 158 |
FALL |
5 |
0.0000 |
| 159 |
DEHYDRATION |
2 |
0.0000 |
| 160 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 161 |
WEIGHT DECREASED |
4 |
0.0000 |
| 162 |
BURNING SENSATION |
1 |
0.0000 |
| 163 |
DYSPNOEA |
8 |
0.0000 |
| 164 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 165 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 166 |
EPISTAXIS |
1 |
0.0000 |
| 167 |
HOT FLUSH |
1 |
0.0000 |
| 168 |
HOSPITALISATION |
2 |
0.0000 |
| 169 |
ARTHRITIS |
1 |
0.0000 |
| 170 |
FEELING ABNORMAL |
3 |
0.0000 |
| 171 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 172 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 173 |
URTICARIA |
2 |
0.0000 |
| 174 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 175 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 176 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 177 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 178 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 179 |
CARDIAC DISORDER |
1 |
0.0000 |
| 180 |
DYSPHAGIA |
1 |
0.0000 |
| 181 |
MIGRAINE |
1 |
0.0000 |
| 182 |
CONTUSION |
1 |
0.0000 |
| 183 |
HEART RATE INCREASED |
1 |
0.0000 |
| 184 |
SYNCOPE |
1 |
0.0000 |
| 185 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 186 |
ILLNESS |
1 |
0.0000 |
| 187 |
INFLUENZA |
1 |
0.0000 |
| 188 |
DEPRESSION |
2 |
0.0000 |
| 189 |
SEIZURE |
1 |
0.0000 |
| 190 |
PALPITATIONS |
1 |
0.0000 |
| 191 |
CHILLS |
1 |
0.0000 |
| 192 |
JOINT SWELLING |
1 |
0.0000 |
| 193 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 194 |
HYPERHIDROSIS |
1 |
0.0000 |
| 195 |
MALAISE |
3 |
0.0000 |
| 196 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 197 |
HYPOAESTHESIA |
1 |
0.0000 |
| 198 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 199 |
PAIN |
4 |
0.0000 |
| 200 |
HEADACHE |
4 |
0.0000 |
| 201 |
NAUSEA |
5 |
0.0000 |
| 202 |
DRUG INTERACTION |
1 |
0.0000 |
| 203 |
DIARRHOEA |
4 |
0.0000 |
| 204 |
TREMOR |
1 |
0.0000 |
| 205 |
DIZZINESS |
3 |
0.0000 |
| 206 |
MYALGIA |
1 |
0.0000 |
| 207 |
PYREXIA |
2 |
0.0000 |
| 208 |
CHEST PAIN |
1 |
0.0000 |
| 209 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 210 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 211 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 212 |
PRURITUS |
2 |
0.0000 |
| 213 |
FATIGUE |
4 |
0.0000 |
| 214 |
SOMNOLENCE |
1 |
0.0000 |
| 215 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 216 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 217 |
OVERDOSE |
1 |
0.0000 |
| 218 |
CONSTIPATION |
1 |
0.0000 |
| 219 |
BACK PAIN |
1 |
0.0000 |
| 220 |
VOMITING |
2 |
0.0000 |
| 221 |
OFF LABEL USE |
3 |
0.0000 |
| 222 |
ARTHRALGIA |
1 |
0.0000 |
| 223 |
DEATH |
2 |
0.0000 |
| 224 |
RASH |
1 |
0.0000 |
| 225 |
DRUG INEFFECTIVE |
2 |
0.0000 |